HEADER TRANSFERASE 12-MAY-14 4D2R TITLE HUMAN IGF IN COMPLEX WITH A DYRK1B INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 985-1286; COMPND 5 SYNONYM: INSULIN-LIKE GROWTH FACTOR RECEPTOR, INSULIN-LIKE GROWTH FAC COMPND 6 IGF-I RECEPTOR, CD221, INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR BETA COMPND 7 CHAIN; COMPND 8 EC: 2.7.10.1; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS TRANSFERASE, KINASE, INHIBITOR, ONCOLOGY EXPDTA X-RAY DIFFRACTION AUTHOR J.E.DEBRECZENI,J.G.KETTLE,P.BALLARD,C.BARDELLE,S.BUTTERWORTH, AUTHOR 2 N.COLCLOUGH,S.E.CRITCHLOW,G.FAIRLEY,S.FILLERY,M.A.GRAHAM,L.GOODWIN, AUTHOR 3 S.GUICHARD,K.HUDSON,A.MAHMOOD,J.VINCENT,R.A.WARD,D.WHITTAKER REVDAT 3 23-OCT-19 4D2R 1 AUTHOR REMARK REVDAT 2 04-APR-18 4D2R 1 REMARK REVDAT 1 22-APR-15 4D2R 0 JRNL AUTH J.G.KETTLE,P.BALLARD,C.BARDELLE,M.COCKERILL,N.COLCLOUGH, JRNL AUTH 2 S.E.CRITCHLOW,J.E.DEBRECZENI,G.FAIRLEY,S.FILLERY,M.A.GRAHAM, JRNL AUTH 3 L.GOODWIN,S.GUICHARD,K.HUDSON,R.A.WARD,D.WHITTAKER JRNL TITL DISCOVERY AND OPTIMIZATION OF A NOVEL SERIES OF DYRK1B JRNL TITL 2 KINASE INHIBITORS TO EXPLORE A MEK RESISTANCE HYPOTHESIS. JRNL REF J.MED.CHEM. V. 58 2834 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 25738750 JRNL DOI 10.1021/ACS.JMEDCHEM.5B00098 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 18.58 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.6 REMARK 3 NUMBER OF REFLECTIONS : 19257 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.181 REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.110 REMARK 3 FREE R VALUE TEST SET COUNT : 984 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.21 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.59 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2530 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1827 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2405 REMARK 3 BIN R VALUE (WORKING SET) : 0.1812 REMARK 3 BIN FREE R VALUE : 0.2141 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.94 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 125 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2340 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 221 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.35 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.82900 REMARK 3 B22 (A**2) : -1.95390 REMARK 3 B33 (A**2) : 0.12490 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.238 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.228 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.179 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.206 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.172 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.940 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.903 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2436 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3301 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 844 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 59 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 351 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2436 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 304 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3078 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.03 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.44 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.96 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|985 - A|1082 } REMARK 3 ORIGIN FOR THE GROUP (A): 21.8758 -4.8564 60.8002 REMARK 3 T TENSOR REMARK 3 T11: 0.1645 T22: 0.0035 REMARK 3 T33: -0.0095 T12: 0.0406 REMARK 3 T13: 0.0065 T23: 0.0789 REMARK 3 L TENSOR REMARK 3 L11: 2.3045 L22: 1.0987 REMARK 3 L33: 1.6214 L12: -0.1003 REMARK 3 L13: -0.3771 L23: -0.3569 REMARK 3 S TENSOR REMARK 3 S11: -0.0538 S12: -0.2134 S13: -0.2757 REMARK 3 S21: 0.2296 S22: -0.0557 S23: -0.1053 REMARK 3 S31: 0.4450 S32: 0.2322 S33: 0.1096 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { A|1083 - A|1286 } REMARK 3 ORIGIN FOR THE GROUP (A): 14.3601 9.0773 39.5309 REMARK 3 T TENSOR REMARK 3 T11: -0.0472 T22: -0.0300 REMARK 3 T33: -0.0692 T12: 0.0027 REMARK 3 T13: 0.0114 T23: -0.0077 REMARK 3 L TENSOR REMARK 3 L11: 1.9810 L22: 0.8840 REMARK 3 L33: 0.9950 L12: -0.1293 REMARK 3 L13: 0.3172 L23: -0.1093 REMARK 3 S TENSOR REMARK 3 S11: -0.0085 S12: 0.2393 S13: -0.0583 REMARK 3 S21: 0.0068 S22: -0.0098 S23: 0.0921 REMARK 3 S31: -0.0212 S32: 0.0002 S33: 0.0183 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: IDEAL-DIST CONTACT TERM CONTACT SETUP. REMARK 3 ALL ATOMS HAVE CCP4 ATOM TYPE FROM LIBRARY REMARK 4 REMARK 4 4D2R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-MAY-14. REMARK 100 THE DEPOSITION ID IS D_1290060609. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-APR-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19300 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 20.540 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 200 DATA REDUNDANCY : 3.680 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.3100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.13 REMARK 200 R MERGE FOR SHELL (I) : 0.34000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.230 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.86 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEF3350, 0.2M MGCL2, 0.1M PCTP PH REMARK 280 7.5, VAPOR DIFFUSION REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.57700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 60.79650 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.24300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 60.79650 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.57700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.24300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1169 REMARK 465 GLY A 1170 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 985 CG OD1 OD2 REMARK 470 ARG A1003 CD NE CZ NH1 NH2 REMARK 470 SER A1009 OG REMARK 470 LYS A1019 CE NZ REMARK 470 LYS A1023 CG CD CE NZ REMARK 470 GLU A1037 CG CD OE1 OE2 REMARK 470 ARG A1042 CG CD NE CZ NH1 NH2 REMARK 470 GLU A1097 CD OE1 OE2 REMARK 470 MET A1098 CG SD CE REMARK 470 THR A1157 OG1 CG2 REMARK 470 ARG A1158 CG CD NE CZ NH1 NH2 REMARK 470 ASP A1159 CG OD1 OD2 REMARK 470 LYS A1171 CG CD CE NZ REMARK 470 ASP A1235 CG OD1 OD2 REMARK 470 LYS A1254 CD CE NZ REMARK 470 GLU A1271 CD OE1 OE2 REMARK 470 ARG A1275 CG CD NE CZ NH1 NH2 REMARK 470 GLU A1276 CG CD OE1 OE2 REMARK 470 LYS A1286 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A1002 -92.03 -122.14 REMARK 500 ARG A1134 -13.98 73.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 2287 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DYK A 2288 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4D2S RELATED DB: PDB REMARK 900 HUMAN TTK IN COMPLEX WITH A DYRK1B INHIBITOR DBREF 4D2R A 985 1286 UNP P08069 IGF1R_HUMAN 985 1286 SEQRES 1 A 302 ASP VAL TYR VAL PRO ASP GLU TRP GLU VAL ALA ARG GLU SEQRES 2 A 302 LYS ILE THR MET SER ARG GLU LEU GLY GLN GLY SER PHE SEQRES 3 A 302 GLY MET VAL TYR GLU GLY VAL ALA LYS GLY VAL VAL LYS SEQRES 4 A 302 ASP GLU PRO GLU THR ARG VAL ALA ILE LYS THR VAL ASN SEQRES 5 A 302 GLU ALA ALA SER MET ARG GLU ARG ILE GLU PHE LEU ASN SEQRES 6 A 302 GLU ALA SER VAL MET LYS GLU PHE ASN CYS HIS HIS VAL SEQRES 7 A 302 VAL ARG LEU LEU GLY VAL VAL SER GLN GLY GLN PRO THR SEQRES 8 A 302 LEU VAL ILE MET GLU LEU MET THR ARG GLY ASP LEU LYS SEQRES 9 A 302 SER TYR LEU ARG SER LEU ARG PRO GLU MET GLU ASN ASN SEQRES 10 A 302 PRO VAL LEU ALA PRO PRO SER LEU SER LYS MET ILE GLN SEQRES 11 A 302 MET ALA GLY GLU ILE ALA ASP GLY MET ALA TYR LEU ASN SEQRES 12 A 302 ALA ASN LYS PHE VAL HIS ARG ASP LEU ALA ALA ARG ASN SEQRES 13 A 302 CYS MET VAL ALA GLU ASP PHE THR VAL LYS ILE GLY ASP SEQRES 14 A 302 PHE GLY MET THR ARG ASP ILE TYR GLU THR ASP TYR TYR SEQRES 15 A 302 ARG LYS GLY GLY LYS GLY LEU LEU PRO VAL ARG TRP MET SEQRES 16 A 302 SER PRO GLU SER LEU LYS ASP GLY VAL PHE THR THR TYR SEQRES 17 A 302 SER ASP VAL TRP SER PHE GLY VAL VAL LEU TRP GLU ILE SEQRES 18 A 302 ALA THR LEU ALA GLU GLN PRO TYR GLN GLY LEU SER ASN SEQRES 19 A 302 GLU GLN VAL LEU ARG PHE VAL MET GLU GLY GLY LEU LEU SEQRES 20 A 302 ASP LYS PRO ASP ASN CYS PRO ASP MET LEU PHE GLU LEU SEQRES 21 A 302 MET ARG MET CYS TRP GLN TYR ASN PRO LYS MET ARG PRO SEQRES 22 A 302 SER PHE LEU GLU ILE ILE SER SER ILE LYS GLU GLU MET SEQRES 23 A 302 GLU PRO GLY PHE ARG GLU VAL SER PHE TYR TYR SER GLU SEQRES 24 A 302 GLU ASN LYS HET CL A2287 1 HET DYK A2288 32 HETNAM CL CHLORIDE ION HETNAM DYK N-{2-METHOXY-4-[(1-METHYLPIPERIDIN-4-YL)OXY]PHENYL}-4- HETNAM 2 DYK (1H-PYRROLO[2,3-C]PYRIDIN-3-YL)PYRIMIDIN-2-AMINE FORMUL 2 CL CL 1- FORMUL 3 DYK C24 H26 N6 O2 FORMUL 4 HOH *221(H2 O) HELIX 1 1 ALA A 995 GLU A 997 5 3 HELIX 2 2 SER A 1040 SER A 1052 1 13 HELIX 3 3 VAL A 1053 PHE A 1057 5 5 HELIX 4 4 ASP A 1086 LEU A 1094 1 9 HELIX 5 5 SER A 1108 ASN A 1129 1 22 HELIX 6 6 ALA A 1137 ARG A 1139 5 3 HELIX 7 7 ARG A 1158 TYR A 1165 5 8 HELIX 8 8 PRO A 1175 MET A 1179 5 5 HELIX 9 9 SER A 1180 GLY A 1187 1 8 HELIX 10 10 THR A 1190 LEU A 1208 1 19 HELIX 11 11 SER A 1217 GLU A 1227 1 11 HELIX 12 12 PRO A 1238 TRP A 1249 1 12 HELIX 13 13 ASN A 1252 ARG A 1256 5 5 HELIX 14 14 SER A 1258 LYS A 1267 1 10 HELIX 15 15 GLU A 1268 MET A 1270 5 3 HELIX 16 16 GLY A 1273 SER A 1278 1 6 SHEET 1 AA 5 ILE A 999 GLN A1007 0 SHEET 2 AA 5 MET A1012 VAL A1022 -1 O VAL A1013 N LEU A1005 SHEET 3 AA 5 GLU A1025 THR A1034 -1 O GLU A1025 N VAL A1022 SHEET 4 AA 5 LEU A1076 GLU A1080 -1 O VAL A1077 N LYS A1033 SHEET 5 AA 5 LEU A1065 VAL A1069 -1 N LEU A1066 O ILE A1078 SHEET 1 AB 2 CYS A1141 VAL A1143 0 SHEET 2 AB 2 VAL A1149 ILE A1151 -1 O LYS A1150 N MET A1142 SHEET 1 AC 2 TYR A1166 ARG A1167 0 SHEET 2 AC 2 LEU A1173 LEU A1174 -1 O LEU A1174 N TYR A1166 CISPEP 1 GLN A 1073 PRO A 1074 0 -2.43 SITE 1 AC1 6 ASN A1127 PHE A1259 LEU A1260 HOH A2032 SITE 2 AC1 6 HOH A2123 HOH A2127 SITE 1 AC2 13 LEU A1005 GLY A1006 GLN A1007 VAL A1013 SITE 2 AC2 13 GLU A1015 ALA A1031 GLU A1080 LEU A1081 SITE 3 AC2 13 MET A1082 THR A1083 GLY A1085 MET A1142 SITE 4 AC2 13 MET A1156 CRYST1 41.154 66.486 121.593 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024299 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015041 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008224 0.00000